Insider Shareholders with Direct Ownership of Sigilon Therapeutics, Inc. (SGTX)
This section provides a comprehensive overview of the insiders with direct ownership of Sigilon Therapeutics, Inc. (SGTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Sigilon Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 0 | 200,000 | 2,022,222 $0 | 1 |
Jun 02, 2021
Reduced 9.0%
|
|
|
Lilly & Co Eli
> 10% Shareholder |
4,462,936 | 0 | 100 $0 | 2 |
Aug 11, 2023
Added 99.99%
|
|
Coelho Rogerio Vivaldi
PRESIDENT AND CEO |
77,750 | 12,169 | 0 $0 | 4 |
Aug 11, 2023
Reduced 100.0%
|
| 6,750 | 6,750 | 0 $0 | 2 |
Jul 01, 2021
Reduced 100.0%
|
|
| 0 | 341 | 0 $0 | 1 |
Aug 11, 2023
Reduced 100.0%
|
|
|
Josias Pontes
CHIEF FINANCIAL OFFICER |
12,944 | 3,504 | 0 $0 | 3 |
Aug 11, 2023
Reduced 100.0%
|
|
Qing Sarah Yuan
CTOO |
2,884 | 2,884 | 0 $0 | 2 |
Aug 11, 2023
Reduced 100.0%
|
|
Matthew Paul Kowalsky
CHIEF OF STAFF AND CLO |
0 | 1,925 | 0 $0 | 1 |
Aug 11, 2023
Reduced 100.0%
|